Related Experiment Videos
Inhibition of cellular chemotactic invasion by a vinca alkaloid, conophylline
1Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan.
Abstract:
K-ras-NIH3T3 cells were more invasive than NIH3T3 cells in a chemotactic invasion assay. Conophylline, a new vinca alkaloid isolated as a ras function inhibitor, inhibited the invasion of K-ras-NIH3T3 cells, while it showed no effect on NIH3T3 cells. Conophylline did not increase expression of fibronectin but induced E-cadherin expression in K-ras-NIH3T3 cells. Mouse melanoma B16/F10 is a highly metastatic cell line. Conophylline was found to induce flat morphology in B16/F10 cells and it again inhibited the invasion of the cells to the matrigel membrane. It induced fibronectin expression but not E-cadherin expression in B 16/F10 cells. Thus, conophylline lowered invasiveness of K-ras-NIH3T3 and B 16/F10 cells by reversing neoplastic phenotypes.
Insights
Conophylline, a ras inhibitor, reduced invasiveness in K-ras-NIH3T3 and melanoma cells. This vinca alkaloid reversed neoplastic phenotypes, offering potential for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Ras proteins are key regulators of cell signaling pathways involved in cancer.
- Cancer cell invasion and metastasis are critical processes in cancer progression.
- Vinca alkaloids are a class of natural compounds with known cytotoxic properties.
Purpose of the Study:
- To investigate the effect of conophylline, a novel ras function inhibitor, on cancer cell invasion.
- To elucidate the molecular mechanisms underlying conophylline's anti-invasive activity.
- To evaluate conophylline's potential as a therapeutic agent against metastatic cancer.
Main Methods:
- Chemotactic invasion assays were performed using K-ras-NIH3T3 and NIH3T3 cells.
- Mouse melanoma B16/F10 cells were used to assess invasion through a matrigel membrane.
- Expression levels of fibronectin and E-cadherin were analyzed in response to conophylline treatment.
Main Results:
- Conophylline significantly inhibited the invasion of K-ras-NIH3T3 cells but not NIH3T3 cells.
- Invasion of highly metastatic B16/F10 melanoma cells was reduced by conophylline.
- Conophylline induced E-cadherin expression in K-ras-NIH3T3 cells and altered morphology in B16/F10 cells.
Conclusions:
- Conophylline effectively reduces cancer cell invasiveness by targeting ras function.
- The compound reverses neoplastic phenotypes, suggesting therapeutic potential.
- Conophylline's distinct effects on fibronectin and E-cadherin highlight context-dependent mechanisms of action.